View of Real-world overall survival of first-line afatinib in EGFR-mutant advanced non–small cell lung cancer at Vietnam National Cancer Hospital

Return to Article Details Real-world overall survival of first-line afatinib in EGFR-mutant advanced non–small cell lung cancer at Vietnam National Cancer Hospital Download Download PDF